Price T Rowe Associates Inc Veru Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VERU
# of Institutions
123Shares Held
56.9MCall Options Held
668KPut Options Held
531K-
Adage Capital Partners Gp, L.L.C. Boston, MA7.86MShares$5.58 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.65MShares$5.43 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY7.28MShares$5.17 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.2MShares$4.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.55MShares$3.94 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $56.9M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....